Proactive Investors - Run By Investors For Investors

Breakfast News - Hurricane Energy; Alliance Pharma; Vast Resources and more...

Breakfast News - Hurricane Energy; Alliance Pharma; Vast Resources and more...

Small Cap Brunch                     

Set menu


Total number of AIM Companies (Incl Susp):


Total number of AIM Companies trading:


*as at close of business  05 July 2018

Standard List**  of Main Market:

Total number of Standard List Companies 

(Incl Susp):


Total number of Standard List Companies trading:


*as at close of business  05 July 2018

NEX Growth Market:

Total number of NEX Growth Market Companies (Incl Susp):


Total number of NEX Growth Market Companies trading: 


*as at close of business  05 July 2018                              

*A corporate client of Hybridan LLP

**  Standard Listing as defined by Hybridan LLP to be a business with strictly operational activity


Dish of the day

Ashoka India Equity Investment Trust (AIE.L Main Mkt, premium) —Target raise £100m. India  focussed high conviction, long-only IT. Raised £45.6m gross at £1.

Off the menu  

No Leavers Today       

What’s cooking in the IPO kitchen?


Ovoca Gold (to be renamed Ovoca Bio PLC) - RTO of IVIX, a Russian company developing a drug candidate for the treatment of female sexual dysfunctions. No monies to be raised, market cap of £8.5m, due 30 July

Nucleus Financial—independent wrap platform provider . FYDec17 revs £40.36m and PBT of £5.1m. Offer TBA. Due late July

Kropz PLC-Intention to float by the  emerging plant nutrient producer with an advanced stage phosphate mining project in South Africa and exploration assets in West Africa


Immotion Group  - aims to become the market leader in "out of home" Immersive Entertainment Experiences. Offer TBA. Due 12 July


Main Market (Premium)

ASA International— “one of the world's largest and most profitable international microfinance institutions, which aims to enhance financial inclusion among low-income populations throughout Asia and Africa in a socially responsible manner”.  Secondary sell down. No primary. Due July. Offer TBA


Main Market (Specialist Funds)

Hipgnosis Songs Fund— offering pure-play exposure to Songs and associated musical intellectual property rights . Targeting £200m raise. Due 11 July

Tritax EuroBox raising up to £300m.  “Will provide an opportunity for investors to gain exposure to a portfolio of well located Continental European logistics real estate assets”. Due 9 July.


Brunch Buffet

Hurricane Energy (LON:HUR) 51.3p £958.4m

“Operational update in relation to the Early Production System development of the Lancaster Field ("Lancaster EPS"). Well completion operations for the Lancaster EPS have concluded, and the Paul B. Loyd Jr. rig has departed from the field. Both production wells for the development are now ready to be tied-in to the subsea infrastructure.

These operations were one of three main elements of the installation campaign for the Lancaster EPS planned to take place during the summer 2018 weather window, the other two being the installation of the mooring system for the FPSO and the installation of the SURF. The installation of the mooring system is currently ongoing and will be followed by the SURF programme. These elements remain on schedule to take place prior to arrival of the FPSO at the field, and first oil remains on target for 1H 2019.”


BCA Marketplace (LON:BCA) 219p £1.7bn

“The Board of BCA Marketplace PLC ("BCA" or the "Company") notes the announcement by Apax Partners LLP ("Apax") that neither Apax nor any funds advised by Apax intend to make an offer for BCA.

The Board of BCA received two preliminary and conditional indicative proposals from Apax relating to a possible cash offer for the entire share capital of BCA (the "Proposals"). After careful consideration, the Board of BCA concluded that the Proposals undervalued the Company and its attractive prospects. Accordingly, the Board of BCA unanimously rejected the Proposals.

The Board of BCA continues to believe in the attractive long term prospects for the Company, and on 28 June 2018, BCA published its preliminary results for the twelve months ended 1 April 2018, delivering a third consecutive year of strong earnings growth.” FYMar19E PE c.18x and yield c.4%,


Alliance Pharma (LON:APH) 98p £503.9m

“The specialty pharmaceutical company, announces that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the UK Marketing Authorisation Application for Diclectin®, a prescription product for the treatment of nausea and vomiting of pregnancy. 

Alliance also confirms that the MHRA has approved the brand name Xonvea®, which will be used for marketing Diclectin in the UK. As previously indicated, Alliance anticipates Xonvea's launch in autumn this year as the only medicine licensed in the UK for the treatment of nausea and vomiting of pregnancy.”

“The Group estimates peak sales for Xonvea in the UK of approximately £10m and across the other nine European countries a further £30m approximately at peak sales.” FYDec18E rev £121m and PBT £28.57m.  Yield c.1.5%.


FairFX (LON:FFX) 114p £177m

“The low-cost multicurrency payments and banking service, is pleased to provide the market with a trading update for the six-month period ended 30th June 2018.

The Company has enjoyed a strong first half of trading, with substantial growth and new products launched. Against this background, strong margins have been maintained and rationalisation of the supply chain is delivering results. “ Turnover for the first half was up 146.2% year on year to £1.1bn, in line with management's expectations. On a like for like basis, excluding the acquired entities of Cardone Banking and City Forex, turnover for the first half was up 22.8% to £532.9m. Like-for-like turnover from prepaid cards and international payments rose 8.5% to £181.7m and 39.1% to £334.6m respectively.” FYDec18E PE c. 23x.


Vast Resources (LON:VAST) 0.57p £30.3m

The mining company with operating mines in Romania and Zimbabwe, is pleased to announce the appointment of Mr Mark Mabhudhu, a preeminent figure in the Zimbabwean diamond industry, to the Board of Vast's wholly owned subsidiary, Vast Resources Zimbabwe (Private) Limited.  Mr Mabhudhu's a­ppointment is in line with the Company's updated strategy to increase its footprint in Zimbabwe, seeking new opportunities and revitalising historic claims.

Mr Mabhudhu, who has a BSc (Hons) degree in metallurgical engineering, an MBA, an MPhil in Information & Knowledge Management, and is currently working on his Doctoral studies, is a full-time resident of Zimbabwe and Zimbabwean national with over 25 years' experience in the mining industry.


Range Resources (LON:RRL) 0.18p £13.29m

Update on Perlak Field Indonesia.  As previously announced, the operator of the project commenced reopening and workover operations on the selected wells. Following the reactivation operations on the first well (POG-D), the well produced 145 barrels of high-quality light oil from one of the multiple production zones over intermittent pumping periods of approximately 117 hours during a two-week timeframe. Further studies and tests are underway to establish a stable production rate. The rig was subsequently mobilised to the second well in the work programme (the POG-E well) and commenced reopening and workover operations on the well. There is a downhole obstruction in the well, which workover operations are attempting to remove. 

Up to 10 wells due to reopen this year. The work programme is expected to add up to 200 bopd of production (gross). The produced oil will be trucked to Pertamina EP Pangkalan Susu field located 153 km away and exclusively sold to Pertamina, an Indonesian state-owned oil and natural gas corporation.          


Impax Asset Management (LON:IPX) 205.5p £268m

“Impax Asset Management Group plc, the specialist investor focused on a more sustainable economy, today provides an update of the development of its assets under discretionary and advisory management ("AUM") for the third quarter of its financial year.

On 30 June 2018, the Company's AUM totalled £11.8bn, representing an increase of 7% over the quarter.

Ian Simm, Chief Executive, commented:

"Twenty years on since the company's inception, Impax continues to make strong progress.  With sustained net inflows, AUM at a record high, and a healthy pipeline of new business, it is clear that investor interest in the transition to a more sustainable economy continues to gather momentum."“


Oakley Capital Investments (LON:OCI) 189p £387.1m

Oakley agrees sale of Damovo to Eli Global

EV. The transaction values Damovo at up to EUR140m

Proceeds: OCI to receive up to £15.4m - a 12% premium to the Dec 2017 carrying value

Uplift: The sale results in an uplift of up to 1p per share on the overall 31 Dec 2017 NAV

Returns: Fund II gross returns are expected to be 5.4x MM, approximately 57% IRR

Under Oakley's ownership, Damovo has been transformed into a recognised European specialist in delivering and managing critical UC&C (Unified communications & collaboration) solutions for enterprise and public-sector organisations.  The business has returned to organic growth by winning and delivering large, multi-year managed services contracts, supported by the integration of three strategic acquisitions. This growth, as well as a more efficient group structure put in place by the experienced management team, has lead to the business more than doubling EBITDA since Oakley's initial investment.


Volution Group (LON:FAN) 204p £405.7m

“The supplier of ventilation products to the residential and commercial construction markets, is pleased to announce that it has acquired Oy Pamon Ab. Pamon is a leading designer, manufacturer and supplier of Mechanical Ventilation with Heat Recovery ("MVHR") products primarily for the Finnish new build and refurbishment construction markets.” Initial cash consideration of EUR11.5m. Deferred cash consideration of up to EUR2

Volution expects the acquisition to be earnings enhancing in the year ending 31 July 2019 .

In the financial year ended 30 Nov 2017, Pamon generated revenue of EUR8.2  (approximately £7.2m). Reported profit before tax was EUR1m (approximately £0.9m) . FY Jul 18E rev £205.98m and PBT £36.68m.


Brave Bison (LON:BBSN) 1.86p £10.7m

“The social video company, is pleased to announce that it has appointed Kate Burns, a former senior Google and AOL executive, to the board as a Non-Executive Director with immediate effect. Kate will also join the remuneration and audit committees on appointment.


Kate has a wealth of experience within the advertising and media industry and is currently a Venture Partner at Hambro Perks, an investment firm. Kate also held a range of roles at Google during her 6 years at the company and was their first employee outside the United States. Before joining Hambro Perks, Kate was CEO of AOL Europe, following which she joined BuzzFeed as European General Manager.”

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use